CoChat

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium *

Csaky, Karl G., Richman, Elaine A., Ferris, Frederick L. · 2008 · Investigative Opthalmology & Visual Science

Overview

Integrity signals

Registry

Crossref · 10.1167/iovs.07-1132

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 265

Metadata

Authors
Csaky, K. G., Richman, E. A., & Ferris, F. L.
Affiliations
  • Duke Medical Center (US)
  • Richman Associates, LLC, Baltimore, Maryland; and the
  • National Institutes of Health (US)
Venue
Investigative Opthalmology & Visual Science
Published
2008-02-01
Volume
49
Issue
2
Pages
479
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W1997000986
Cited by
265
References
16
Citations by year
2026: 17 · 2025: 26 · 2024: 22 · 2023: 10 · 2022: 15 · 2021: 16 · 2020: 16 · 2019: 13 · 2018: 9 · 2017: 17 · 2016: 17 · 2015: 13 · 2014: 13 · 2013: 9 · 2012: 10
FWCI
12.61
Type
journal article
Language
en
Open access
closed
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Food and Drug Administration
  • National Eye Institute
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
Keywords
ophthalmic clinical trials, clinical trial design, clinical trial endpoints, ophthalmic drug development
MeSH terms
Atrophy, Clinical Trials as Topic, Diabetic Retinopathy, Humans, Macular Degeneration, National Institutes of Health (U.S.), Ophthalmology, Pigment Epithelium of Eye, Product Surveillance, Postmarketing, Research Design, United States, United States Food and Drug Administration, Visual Acuity, Treatment Outcome, Patient Satisfaction, Choroidal Neovascularization, Endpoint Determination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.